Summary The pressure-time index (PTI ¼ P mouth =P i max Â T i =T tot ) has been validated by Ramonatxo (J. Appl. Physiol. 78 (1995) 646 and by Jabour (Am. Rev. Respir. Dis. 144 (1991) 531 as a noninvasive tool for the assessment of inspiratory muscles load. Nobody until now has evaluated the correlation between the PTI and diaphragmatic activity. Further, the PTI has not been compared with another measures of respiratory muscle load such as the transdiaphragmatic pressure index or TT di : The purpose of our study was to test the hypothesis that the PTI measured at the mouth (PTI m ) is a noninvasive reflection of TT di and electromyographic activity of the diaphragm (EMG di ). We studied 6 patients with COPD and 5 normal individuals at rest and during a CO 2 rebreathing trial and simultaneously measured PTI m , TT di and EMG di . The curves of PTI m and EMG di follows the same trend during the CO 2 rebreathing trial with strong and significant correlation between these parameters (r ¼ 0:89 Po0:05 and r ¼ 0:82 Po0:05 for PaCO 2 of 45 and 53 mmHg respectively). We conclude that PTI m measured as P mouth =P i max ÂT i =T tot is an adequate noninvasive method that reflect not only the diaphragmatic activity but also the inspiratory muscles load. r
Introduction
The global activity of the inspiratory muscles can be evaluated by different invasive techniques. The tension-time diaphragmatic index (TT di ) developed by Bellemare and Grassino 1 assesses the activity of the diaphragm by measuring the transdiaphragmatic pressure (P di ) during breathing as a function of the maximal transdiaphragmatic pressure (Pd i max ) and the duty cycle or T i =T tot where T i is inspiratory time and T tot is total time of the breathing cycle. A more direct measurement is the analysis of the electromyographic signal obtained from the diaphragm. Whether the time or the frequency domains are analyzed, this test and the TT di requires the placement of esophageal electrodes and/or balloons. Both measurements have enjoyed great academic interest but the practical problems they pose have meant that they are only used in research protocols and seldomly in daily clinical practice.
In 1992, Jabour et al. 2 suggested that substituting the P es =P es max by P breath =P i max (where P breath is the mean inspiratory pressure during the inspiration in order to generate a breath and P i max the maximal static inspiratory pressure) can be used to assess the balance between the intensity of the inspiratory load and the reserve available to accomplish it. They coined the term PTI or pressure time index (P mouth /Negative inspiratory pressure Â T i =T tot ). However this index was developed in mechanically ventilated patients, where P breath ¼ P pk Â VT SB =VT MV ; P pk is ventilator peak inspiratory pressure, VT SB is tidal volume during spontaneous breathing and VT MV is tidal volume on mechanical ventilation. Furthermore, the hypothesis was never tested in spontaneously breathing patients or normal individuals. In 1995 Ramonatxo and co-workers 1 also developed a similar noninvasive tension-time index for all of the inspiratory muscles:
where Pi is the mean inspiratory pressure estimated as 5P 0.1 Â T i as described by Gaultier et al. 3 In this method, P 0:1 means the mouth pressure at 100 ms of an occluded inspiration. The authors concluded that the TT mus is a valid noninvasive and clinical tool to evaluate inspiratory muscle load. However, the measurement requires the determination of mouth occlusion pressure a test that requires special equipment and is subject to significant variations. 4 We reasoned that the PTI could be simplified if the mean pressure was measured at the mouth (PTI m ) and expressed as fraction of the P i max while the duty cycle was determined with a pneumotachograph. The aim of this study is to prove this hypothesis.
Methods Subjects
In the patients, the diagnosis of COPD was made according to the American Thoracic Society guidelines. 5 The patients were free of other comorbid cardiovascular disease, and at the time of the evaluation all were in clinically stable state without exacerbation for at least 3 months. The study was approved by the Human Studies Review Board, and each subject gave informed consent.
Measurements
Pulmonary function tests Spirometry was measured with a calibrated dry seal spirometer (Sensormedics; Yorba Linda, CA). 6 The predicted values for spirometric and thoracic gas volumes were those of Morris et al. 7 All measurements were obtained with the subjects sitting in a comfortable position. Once stable, the subjects breathed through a low resistance pneumotachograph (Model 4813, R ¼ 0:3 m 2 /L/min at up to max flow of 800 L/min, Hans Rudolph, Kansas City, MO). The pressure differential was determined using a transducer (MP457150 cm H 2 O, Validyne, Northridge, CA) connected to an amplifier (Validyne CD12, Northridge, CA). The flow signal was sampled at 12 bits and at 1000 Hz and digitized using a commercially available software program (DataqQ instruments, Akron, OH). The inspiratory (T i ) and expiratory time (T e ) were defined by the points of zero flow. T tot was obtained by adding the T i to T e :
Respiratory muscle function Esophageal pressure (P es ) was measured with a 10 cm thin walled balloon attached to a polyethylene catheter (1.66 mm of internal diameter, 87 cm long, Ackrad Laboratories, Inc; Cranford, NJ) positioned in the lower third of the esophagus. 8 The catheter was connected to one side of a differential pressure transducer (MP457150 cm H 2 O, Validyne, Northbridge, CA) Gastric pressure (P ga ) was also measured using a 10 cm long thinwalled balloon positioned in the stomach connected to another pressure transducer (MP457150 cm H 2 O, Validyne, Northbridge, CA). Mean transdiaphragmatic pressure (P di ) for each breath was calculated as the algebraic difference between P ga and P pl (P di ¼ P ga À P pl ). Maximal P di (P di max ) was measured at functional residual capacity (FRC). The P i max pressure was measured at RV in the sitting position with another pressure traducer (MP457300 cm H 2 O, Validyne, Northbridge, CA), using the technique of Black and Hyatt. 9 Procedures were carefully explained to all subjects in order to obtain an appropriate maneuver. The subjects were asked to perform a maximal effort against an occluded airway and to maintain the maximal pressure for at least 1 s. Repeated measurements were made until 3 technically satisfactory measurements were obtained (variation o10%). The reported data represent the best values.
We calculated then two different tension time indices: PTI m based on the formula PTI ¼ P mouth =P i max ÂT i =T tot ; and TT di based on the index developed by Bellemare and Grassino 10 (TT di ¼ P di =P di max Â T i =T tot ). Where P mouth ¼ the mean inspiratory pressure, P i max ¼ maximal inspiratory pressure, P di ¼ mean transdiaphragmatic pressure, P di max ¼ maximal transdiaphragmatic pressure, T i ¼ inspira-tory time and T tot ¼ total time of the respiratory cycle. The mouth pressure during tidal and CO 2 response breathing was registered proximal to the pneumotachograph screen, using a pressure transducer (Valdyne MP45, linear from 0 to 40 cmH 2 O, Northridge, CA).
Electromyographic signal
An esophageal electrode was constructed as described and modified by Aldrich et al. 11, 12 and then validated in normal individuals and COPD patients by Sinderby and co-workers. 13 Two lengths of Teflon TM insulated fine platinum wire were threaded trough 100 cm of polyethylene tubing and exteriorized. Each electrode consisted of multiple turns of stripped wire. The recording length was 6 mm per electrode and the intraelectrode distance was 12 mm. The esophageal electrode was passed transnasally during or after placement of the esophageal and gastric balloons. Optimal position was determined as that which resulted in the maximal inspiratory diaphragmatic EMG signal during a sniff maneuver as visualized on the strip chart recording. To prevent displacement, the proximal end of the electrode was taped to the nose. EMG signals were amplified (DISA 15C01 amplifier, Springfield, MA), band-passed filtered at 10 and 2000 Hz and displayed on the chart recorder. The signal was then filtered again at 20 and 400 Hz to eliminate motion artifact and reduce noise. The filtered signal was digitized at 1000 Hz with an analog-to-digital converter and stored for analysis.
Control of breathing
The CO 2 rebreathing test was performed according to the method originally described by Read 14 and then modified by Elliot et al. 15 for the measurements of P 0:1 in mouth and esophagus. The system was calibrated and tested with an independent pressure traducer system. Patients were sitting comfortably and connected to a closed circuit where they breathed from a rubber bag containing a mixture of 5-7% CO 2 and 93-95% oxygen. In that bag, CO 2 concentration increased since the CO 2 exhaled by the patient was not absorbed. End-tidal P CO 2 ðP ET CO 2 Þ was analyzed with the mass spectrometer. The test was stopped when the subjects could no longer continue the test and achieved a P ET CO 2 460 mmHg: All subjects included met these criteria and had at least four values for analysis. Flow at the mouth was measured using a pneumotachograph and minute ventilation ( _ V V E ), tidal volume (V T ) and respiratory frequency were calculated. P 0:1 was measured using a pressure transducer. The occlusion pressure valve was occluded automatically at random 2-3 times per minute.
Analysis
At rest and at increasing exhaled CO 2 concentrations (4-8%); tidal volume (V t ), respiratory frequency (f), minute ventilation ( _ V V E ), inspiratory time (T i ), total time of breathing cycle (T tot ), T i =T tot ; mean P di ¼ mean P es þ mean P ga ; and mean P mouth were determined. To assure uniformity and avoid bias, the calculations were made in the 3 tidal breaths preceding the mouth occlusion pressure maneuvers. Mean P mouth ; P di ; P es and P ga were determined during the same breaths using a computer generated algorithm (DataqQ instruments, Akron, OH). All values reported correspond to the average of all the measurements.
EMG analysis
The digitized EMG data was analyzed from the signal registered during the corresponding breaths selected for the pressure and flow analysis. Individual breaths were analyzed with EMG data partitioned into 250 ms windows for the fast Fourier transform routine. Data for each breath consisted of five consecutive 250 ms time windows with the beginning of the first time window selected as the initial downward deflection of the inspiratory flow signal. Each 250 ms window was manually examined to exclude artifact and to gate ECG complexes. 16 Diaphragmatic EMG windows containing ECG, QRS activity were excluded from further analysis. Rootmean-square amplitude (RMS) was determined in the time domain. The data reported in the analysis is the mean RMS obtained from all values included in an inspiratory cycle of a breath.
Statistics
The data presented is the quartiles of the measured values for each group, COPD patients and normals. Spearman's correlation was used to study the association of the different variables measured, for each group. To compare the location of the variables in the two groups we used the MannWhitney U rank test. Values of Po0:05 were considered significant.
Results
We studied 6 consecutive patients with COPD and 5 normal individuals whose anthropometric and physiologic characteristics are given in Table 1 . Patient demographics and physiologic characteristics are shown in Table 1 . As expected, the patients had severe airflow obstruction. Normal subjects had normal spirometry. The median and quartiles for PTI m , TT di and EMG RMS activity at rest (PaCO 2 438 mmHg) and at PCO 2 of 45, 53 and 65 mmHg for the subjects are shown in Table 2 . Fig. 1 shows that the median values for PTI m and EMG RMS activity were higher for the COPD patients than normal individuals throughout the CO 2 rebreathing test (Mann-Whitney U rank, Po0:05). As expected, all the values increased as CO 2 increased expressed by the equation PTI m ¼ 0.0025-0.0003 (pCO 2 mmHg) for COPD patients and PTI m ¼ 0.0010-0.0002 (pCO 2 mmHg) for normals. Table 3 shows that there was no correlation at rest between PTI m with TT di (r ¼ 0:33) and EMG RMS (r ¼ 0:34). Table 3 also shows the correlations during the CO 2 rebreathing test between PTI m and TT di (r ¼ 0:73 for P CO 2 45, r ¼ 0:54 for P CO 2 ¼ 53) and PTI m and EMG RMS (r ¼ 0:89 for P CO 2 45, r ¼ 0:82 for P CO 2 ¼ 53). The correlation between PTI m , TT di ; and EMG RMS decreased again, at P CO 2 levels of 65 mmHg (r ¼ 0:38 and r ¼ 0:18; respectively). Fig. 2 shows the real time P pl ; P ga ; P m ; flow and EMG signal of a typical patient and a normal volunteer at rest and at 53 mmHg P CO 2 : The values were higher for COPD patients, increasing as CO 2 increased.
Discussion
The main finding of this study was the validation of the noninvasive PTI m index in normals and COPD patients, using for comparison the EMG RMS of the diaphragm as the gold standard. We proved that the simple PTI m measured at the mouth is a good index of respiratory muscle load. The PTI was proposed by Jabour et al in 1992 2 as a potential tool to predict the probability of weaning in mechanically ventilated patients. In that study, the pressure load or P breath was defined by the peak pressure measured at the ventilator (P peak ) and the spontaneous tidal volume as a ratio of the tidal volume on the ventilator. The applicability of these measurements in spontaneously breathing patients was never tested. Subsequently, Ramonaxto and co-workers in 1995 1 studied a simpler version of the PTI in resting healthy subjects and patients with COPD. This index was calculated using the PI=P i max ; however, the mean PI was estimated from the formula PI ¼ 5P0:1 Â TI as described by Gaultier et al., 3 therefore requiring the measurement of P 0:1 : Recently Hayot et al. 17 also validated this index in healthy subjects during an exercise test. In this study, the correlation between TT mus and TT di during an exercise test was good for normal individuals and poor for COPD patients.
ARTICLE IN PRESS
Our study shows that the PTI m and the EMG RMS were higher in the COPD group than in normal individuals. Interestingly, the range of values found in our study were very similar to those reported by Hayot et al. 17 in their study. That the EMG activity of the diaphragm is increased in COPD was also demonstrated by Sinderby et al. 12 This could be explained by the fact that COPD patients have a increase central output, measured by either P 0.1 or EMG activity as previously demonstrated by Marin et al. 18 However, PTI m showed the highest and significant correlation with the EMG RMS at exhaled concentrations of 45 and 53 mmHg. This implies that although all these measurements evaluate the same parameter, that is the central output and the neuromechanical coupling, the PTI m seems to reflect the actual activation of the working muscles as a whole.
The curves that represent the progression of the PTI and the EMG activity during the CO 2 rebreathing test (Fig. 1) demonstrate that the PTI faithfully track the EMG activity and hence represent the load on the system. We do not pretend that the PTI m as here calculated, is the only or best way to measure respiratory muscle load, however, it is the most simple and practical. As shown in Table 4 , if we compare the values with those obtained in our population, using the methods described by Hayot and co-workers 17 and Ramonatxo et al. 1 The results are not too different. Given its simplicity, the new PTI m may be more attractive to clinicians.
An interesting finding of our study was that at rest and during the final part of the CO 2 rebreathing test the correlation between the different invasive and noninvasive parameter become weaker and nonsignificant. We explained this finding by the fact that patients at these periods developed different ventilatory strategy, using their diaphragm and accessory muscles alternatively. When this occurs, the EMG of the diaphragm may actually underestimate the degree of activation of other muscles that continue to participate in the genesis of increased pressures but not to the generation of increased EMG di .
The most important limitation of our study is the relatively small number of subjects included. This is due to the complexity of the protocol. However, the statistically significant positive associations and correlations between PTI m and the other indices, render our findings even more meaningful. In addition, the narrow range of COPD severity and the fact that normal individuals were younger could make our findings only applicable to this population. In this regard, the inclusion of normals and its positive correlations make the argument a little less valid. Further studies will allow testing the actual value of this index in other populations.
In summary, the PTI m has a good correlation with the other invasive and noninvasive methods known to evaluate the inspiratory activity of the respiratory system, at rest and during increased ventilatory demand. We propose that the PTI m could be an easy noninvasive and practical way to evaluate the inspiratory load of the respiratory system in clinical practice. There is already data evaluating the use of tension-time indexes in inspiratory muscles of COPD patients at rest, 19 during exercise 17 and examining the effects of expiratory resistive load in COPD patients. 20 The role of PTI m in the management of patients in acute or chronic respiratory failure, in the weaning process from the mechanical ventilation or to determine the utility of noninvasive positive pressure ventilation remains to be determined. 

